FOSL1 and breast hyperplasia: As far as breast hyperplasias are concerned, we observed no different FRA-1 protein levels between atypical and typical breast hyperplasias, but the FRA-1 immunolocalization was essentially present in the nuclei in the atypical lesions, whereas the typical lesions showed a mainly cytoplasmic staining.